首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1722973

2025 年至 2033 年生物反應器市場規模、佔有率、趨勢及預測（按類型、用途、規模、控制類型和地區）

Bioreactors Market Size, Share, Trends, and Forecast by Type, Usage, Scale, Control Type, and Region, 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024 年全球生物反應器市場規模價值 80 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 196 億美元，2025-2033 年期間的複合年成長率為 10.4%。北美目前佔據市場主導地位，到 2024 年將佔據超過 39.1% 的顯著市場。有效治療藥物的採用率不斷提高，以及對預防性疫苗的需求不斷成長，主要推動了生物反應器市場佔有率的成長。

由於對單株抗體和疫苗等生物製劑的需求不斷成長，全球生物反應器市場正在經歷成長。這可以歸因於生物製藥生產的進步。同時，一次性生物反應器的日益普及（以降低污染風險和營運成本而聞名）進一步加速了市場成長。細胞和基因治療研究的快速進步以及對個人化醫療日益成長的興趣也在推動需求。除此之外，政府對生物製劑製造的支持和對生物相似藥生產的有利規定也促進了市場的擴張。此外，自動化和控制系統的技術改進正在提高生物反應器的性能，滿足生物技術和製藥行業的需求，並推動市場發展。

由於對生物相似藥生產的日益關注，美國成為關鍵市場。主要生物製劑的專利到期以及這些替代品的價格越來越便宜，都證明了這一點。此外，慢性病的日益普及也促進了生物製藥的投資，從而推動了對可擴展、高效的生物反應器系統的需求。根據美國疾病管制與預防中心2024年的研究報告，美國有1.29億人患有至少一種美國衛生與公眾服務部定義的主要慢性疾病，如心臟病、癌症、糖尿病、肥胖症或高血壓，其中42%的人患有兩種或兩種以上疾病，12%的人患有至少五種疾病。在十大死因中，慢性病佔了五分之一。二十年來，其發生率穩定上升，預計還會進一步上升。除此之外，幹細胞研究和組織工程等生物加工應用的擴展對專用生物反應器產生了巨大的需求。同時，學術機構和生技公司的合作正在加速生物製造技術的進步。此外，生物反應器在食品和農業生物技術中的作用日益增強，為生物反應器市場創造了積極的前景。

生物反應器市場趨勢：

一次性生物反應器的使用

一次性生物反應器 (SUB) 因其靈活性、成本效益、降低污染風險等優點而越來越受歡迎。這反過來又刺激了市場的發展。根據 IMARC 的數據，2023 年全球一次性生物反應器市場規模達 34 億美元。展望未來， IMARC Group預計到 2032 年市場規模將達到 111 億美元，從而在 2024-2032 年期間的成長率 (CAGR) 為 13.8%。此外，與傳統的不銹鋼生物反應器不同，SUB 採用一次性袋子，這有助於消除批次之間進行大量清潔和消毒的需要。 2023 年 12 月，Cellexus 推出了氣升式拋棄式生物反應器系統，為細胞的快速生長提供最佳通氣。這種輕柔攪拌的方法通常適用於微生物發酵和細胞培養。除此之外，主要參與者也正在生產創新的 SUB 設計，以滿足小規模研究和大規模生產的需求，這推動了生物反應器市場的發展。例如，2024 年 2 月，合約開發和製造組織 (CDMO) 藥明生物宣佈在愛爾蘭投資約 3.4 億美元建造一個一次性生物反應器容量約為 54,000 公升的一次性工廠。此外，2024 年 3 月，賽默飛世爾科技 (TM) 針對 HyPerforma (TM) 一次性生物反應器 (SUB) 產品平台推出了一系列針對特定應用的增強功能，每個功能都針對強化補料分批、灌注和貼壁細胞培養的獨特要求進行客製化。同樣，2024 年 3 月，Distek, Inc. 推出了用於哺乳動物細胞生長和重組蛋白生產的一次性生物反應器 (SUB) 系統。此外，預計未來幾年知名公司之間的持續合作將擴大市場。例如，2024年6月，Aragen Bioscience與Getinge宣布後者的一次性生產反應器（SUPR）成功驗證。為此，此次合作結合了 Getinge 的創新一次性技術與 Aragen 在生物製藥製造方面的專業知識。

自動化的進步

生物反應器市場的一個重要趨勢是自動化的不斷進步。新型控制系統和自動化與生物反應器的廣泛整合正在徹底改變生物加工，實現對關鍵參數（如 pH、溫度、溶解氧等）的精確控制和即時監控。這是一個重要的成長誘導因素。例如，2023 年 8 月，Repligen Corporation 和 Sartorius 推出了一款整合式生物反應器系統，該系統包含完全相容的嵌入式 XCell ATF 軟體和硬體模組，可提供預先定義的高級控制配方以及整合製程分析技術 (PAT)。 Gartner 預測，到 2026 年，30% 的企業將實現超過一半的網路活動自動化，高於 2023 年的 10%，因為包括 GenAI 在內的人工智慧驅動的自動化將提高營運效率和靈活性。這些進步擴大應用於生物反應器，增強了數據驅動的決策和流程最佳化。此外，該系統旨在為使用者提供一種簡化的方法來控制細胞生長並增強灌注過程中的細胞保留，而無需使用單獨的細胞保留控制塔。此外，2023 年 9 月，生物技術解決方案創新者之一 Automated Control Concepts (ACC) 發布了其尖端生物反應器控制和資料平台 Lab Owl，該平台允許調整多個過程參數和進行精確監控，從而獲得一致且可重複的結果。除此之外，2023年12月，Cultzyme推出了配備人工智慧、硬體和雲端運算的生物反應器智慧操作奈米技術（BION）系統，以控制生物製造過程，並以最低成本更有效率地實現一致的結果。此外，先進控制系統的需求不斷成長，因為它們促進了從實驗室到生產規模的無縫擴大，有助於確保多種生物反應器尺寸的一致性能，這也增加了生物反應器市場的收入。例如，2024 年 4 月，Culture Biosciences 創建了具有先進控制系統和即時監控功能的生物反應器，旨在容納中國倉鼠卵巢 (CHO) 細胞。

永續生物加工的發展

永續性正成為市場的一個重要考量。知名企業正致力於最大限度地減少能源消耗和廢物產生，這刺激了生物反應器市場的成長。 2023 年 10 月，奈良先端科學技術大學院大學和藤田大學的一組研究人員推出了一種混合電腦模擬/細胞內控制器 (HISICC)，將電腦前饋控制與基因改造活細胞無縫整合，為經濟高效且環保的化學品和燃料生產提供了潛力。除此之外，2023 年 11 月，ADM 和 Solugen 建立戰略合作夥伴關係，建造一個約 50 萬平方英尺的生物製造工廠，開發分子以取代現有的化石燃料基材料並擴大其低碳有機酸產品線。例如，英國已在 21 個跨部門合作中投資約 1400 萬美元，以推進永續生物製造，重點關注生物反應器創新和生物催化過程，例如用於生產乙醯胺酚的可擴展連續流反應器。這些措施旨在提高生物技術過程的永續性，並支持英國在2050年實現淨零排放的目標。此外，生物反應器製造商正在投資生物反應器設計的多項創新，例如更高效的混合和曝氣系統，這正在提升更環保的生物加工解決方案的普及度。例如，勃林格殷格翰在動物保健領域提供生物製程技術操作，並更加重視環境永續性。與此相符的是，從不斷討論和評估當前的實踐到最佳化抗原生物製造的工藝鏈，該公司堅定地致力於最大限度地減少其對環境的影響。此外，2024 年 3 月，英國研究與創新署 (UKRI) 宣布 21 項跨部門合作，以推動全國永續生物製造的進步。

The global bioreactors market size was valued at USD 8.0 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 19.6 Billion by 2033, exhibiting a CAGR of 10.4% during 2025-2033. North America currently dominates the market, holding a significant market share of over 39.1% in 2024. The increasing adoption of effective treatment drugs, along with the rising need for preventive vaccines, is primarily propelling the bioreactors market share.

The global bioreactors market is experiencing growth due to the rising demand for biologics, including monoclonal antibodies and vaccines. This can be attributed to the advancements in biopharmaceutical production. Along with this, the increasing adoption of single-use bioreactors, known for reduced contamination risks and operational costs, is further accelerating market growth. Rapid advancements in cell and gene therapy research, and growing interest in personalized medicine, are also propelling demand. Apart from this, government support for biologics manufacturing and favorable regulations for biosimilar production are contributing to the market's expansion. Moreover, technological improvements in automation and control systems are enhancing bioreactor performance, addressing the needs of the biotechnology and pharmaceutical industries, and fueling the market.

The United States stands out as a key market, driven by the growing focus on biosimilar production. This can be supported by the patent expirations of major biologics and the increasing affordability of these alternatives. In addition, the increasing prevalence of chronic diseases is encouraging biopharmaceutical investments, fueling the need for scalable and efficient bioreactor systems. As per 2024 research report by the CDC, in the United States, 129 million individuals have at least one major chronic disease defined by the US Department of Health and Human Services, such as heart disease, cancer, diabetes, obesity, or hypertension, with 42% having two or more and 12% having at least five. Chronic diseases account for five of the top 10 leading causes of death. Their prevalence has steadily increased over two decades and is expected to rise further. Besides this, expansion in bioprocessing applications, such as stem cell research and tissue engineering, is creating significant demand for specialized bioreactors. Concurrently, collaborations between academic institutions and biotech companies are accelerating advancements in biomanufacturing techniques. Furthermore, the increasing role of bioreactors in food and agricultural biotechnology is creating a positive bioreactors market outlook.

Bioreactors Market Trends:

Usage of Single-Use Bioreactors

Single-use bioreactors (SUBs) are gaining extensive popularity, owing to their benefits, such as flexibility, cost-effectiveness, reduced risk of contamination, etc. This, in turn, is stimulating the market. According to the IMARC, the global single-use bioreactors market size reached USD 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach USD 11.1 Billion by 2032, thereby exhibiting a growth rate (CAGR) of 13.8% during 2024-2032. Moreover, unlike traditional stainless-steel bioreactors, SUBs adopt disposable bags, which aids in eliminating the need for extensive cleaning and sterilization between batches. In December 2023, Cellexus introduced airlift single-use disposable bioreactor systems that offer optimal aeration for the rapid growth of cells. This method of gentle agitation is usually suitable for microbial fermentation and cell culture. Besides this, key players are also producing innovative SUB designs, catering to both small-scale research and large-scale production needs, which is fueling the bioreactors market outlook. For instance, in February 2024, the contract development and manufacturing organization (CDMO), WuXi Biologics, announced the construction of a single-use site with approximately 54,000 L of disposable bioreactor capacity via an investment of roughly approximately USD 340 Million in Ireland. Additionally, in March 2024, Thermo Fisher Scientific(TM) launched a series of application-specific enhancements to the HyPerforma(TM) single-use bioreactor (SUB) product platform, each tailored to the unique requirements of intensified fed-batch, perfusion, and adherent cell cultures. Similarly, in March 2024, Distek, Inc. unveiled a single-use bioreactor (SUB) system for mammalian cell growth and recombinant protein production. Furthermore, continuous collaborations among prominent companies are projected to augment the market in the coming years. For example, in June 2024, Aragen Bioscience and Getinge announced the successful validation of the latter's single-use production reactors (SUPR). In line with this, the collaboration combined Getinge's innovative single-use technology and Aragen's expertise in biopharmaceutical manufacturing.

Advancements in Automation

On of the significant bioreactors market trends is continual advancements in automation. The widespread integration of novel control systems and automation with bioreactors is revolutionizing bioprocessing by enabling precise control over critical parameters, such as pH, temperature, dissolved oxygen, etc., and real-time monitoring. This is acting as a significant growth-inducing factor. For instance, in August 2023, Repligen Corporation and Sartorius introduced an integrated bioreactor system that comprises a fully compatible embedded XCell ATF software and hardware module offering predefined advanced control recipes with integrated process analytical technology (PAT). According to Gartner, by 2026, 30% of enterprises will automate over half of network activities, up from 10% in 2023, as AI-driven automation, including GenAI, boosts operational efficiency and agility. These advancements are increasingly applied in bioreactors, enhancing data-driven decision-making and process optimization. Additionally, the system aims to provide users with a streamlined way to control cell growth and enhance cell retention in perfusion processes without utilizing a separate cell retention control tower. Besides this, in September 2023, Automated Control Concepts (ACC), one of the innovators in biotechnology solutions, released its cutting-edge bioreactor control and data platform, Lab Owl, that allows for adjustment of multiple process parameters and precise monitoring, resulting in consistent and reproducible outcomes. Apart from this, in December 2023, Cultzyme launched a bioreactor intelligent operative nanotechnology (BION) system equipped with AI, hardware, and cloud computing to control the biomanufacturing process and achieve consistent outcomes more efficiently and at minimal costs. Furthermore, the escalating demand for advanced control systems, as they facilitate seamless scale-up from laboratory to production scale, which aids in ensuring consistent performance across numerous bioreactor sizes, is also increasing the bioreactors market revenue. For instance, in April 2024, Culture Biosciences created bioreactors with advanced control systems and real-time monitoring capabilities designed to accommodate Chinese Hamster Ovary (CHO) cells.

Development of Sustainable Bioprocessing

Sustainability is becoming a critical consideration in the market. Prominent players are focusing on minimizing energy consumption and waste generation, which is stimulating the bioreactors market growth. In October 2023, a team of researchers at the Nara Institute of Science and Technology and Fujita University introduced a hybrid in silico/in-cell controller (HISICC) that seamlessly integrates computerized feedforward control with genetically modified living cells, offering the potential for cost-effective and eco-friendly chemical and fuel production. Besides this, in November 2023, ADM and Solugen formed a strategic partnership to build an approximately 500,000-ft2 biomanufacturing facility to develop molecules to replace existing fossil fuel-based materials and scale its line of lower-carbon organic acids. For instance, the UK has invested approximately USD 14 Million in 21 cross-sector collaborations to advance sustainable biomanufacturing, focusing on bioreactor innovations and biocatalytic processes, such as scalable continuous flow reactors for paracetamol production. These initiatives aim to enhance the sustainability profile of biotechnology processes and support the UK's goal of achieving Net Zero by 2050. Moreover, bioreactor manufacturers are investing in several innovations in bioreactor design, such as more efficient mixing and aeration systems, which is elevating the popularity of greener bioprocessing solutions. For example, Boehringer Ingelheim offers bioprocess technology operations in animal health with an improved focus on environmental sustainability. In line with this, from continuously discussing and evaluating current practices to optimizing process chains for antigenic biological manufacturing, the company is strongly committed to minimizing its environmental footprint. Additionally, in March 2024, the UK Research and Innovation (UKRI) announced 21 cross-sector collaborations to drive advancements in sustainable biomanufacturing across the country.

Bioreactors Industry Segmentation:

Analysis by Type:

Single-Use
Multi-Use

Multi-use stands as the largest component in 2024, holding around 65.9% of the market. Multi-use bioreactors are the most versatile, cost-effective, and efficient bioreactors for diverse bioproduction processes. They are used in a wide range of pharmaceutical, biotechnology, and research applications because they can accommodate various cell culture and fermentation processes. Their design is robust, reusable, and scalable, making them ideal for large-scale manufacturing and experimental applications. Multi-use bioreactors are in line with the industry's demand for high-quality production and sustainable practices, as they reduce operational costs and ensure consistent performance. Their adaptability to advanced technologies further reinforces their position as the largest and most impactful segment in the bioreactors market.

Analysis by Usage:

Lab-Scale Production
Pilot-Scale Production
Full-Scale Production

Pilot-scale production leads the market with around 49.1% of market share in 2024. Pilot-scale production in bioreactors serves as a crucial intermediary step between laboratory research and full-scale manufacturing in the biopharmaceutical industry. This phase allows for the optimization of bioprocesses on a scale that closely mimics commercial production, providing valuable insights into process performance, scalability, and reproducibility. Pilot-scale bioreactors typically range from 50 to 500 liters in capacity. For instance, in January 2024, San Francisco-based SciFi Foods announced the successful completion of its first commercial bioreactor facility in San Leandro, California. They are used to test and refine production parameters such as cell growth, nutrient consumption, and product yield under conditions that replicate those of large-scale operations. Additionally, pilot-scale production facilitates regulatory compliance by generating data required for process validation and quality assurance. Companies like GE Healthcare and Sartorius offer advanced pilot-scale bioreactor systems equipped with sophisticated monitoring and control technologies, enabling precise control over critical process parameters and ensuring a seamless transition to large-scale manufacturing.

Analysis by Scale:

5L-20L
20L-200L
200L-1500L
Above 1500L

200L-1500L leads the market with around 47.8% of market share in 2024. Bioreactors are designed in various scales to meet the needs of different stages of bioprocessing, from research and development to full-scale commercial production. Bioreactors in the 200L to 1500L range are used for pilot-scale production, providing a realistic simulation of commercial-scale operations and facilitating the validation of production processes. These bioreactors hold significant prominence in the biopharmaceutical sector due to their versatility and scalability. These systems bridge the gap between laboratory-scale research and large-scale manufacturing, enabling efficient process optimization and technology transfer. Their adoption is driven by the rising demand for biologics, including monoclonal antibodies and vaccines, which require consistent and reproducible production environments.

Analysis by Control Type:

Manual
Automated

Automated leads the market with around 65.9% of market share in 2024. Automated bioreactors are revolutionizing bioprocessing by integrating advanced control systems that enhance precision, efficiency, and scalability. They allow for real-time monitoring and control of critical parameters, including temperature, pH, dissolved oxygen, etc. The system's automation capabilities minimize human intervention, thereby reducing the risk of contamination and errors while optimizing cell growth and product yield. For example, in May 2024, a team of researchers at Florida International University developed an automated 3D-printed bioreactor to grow bone in the lab. Additionally, biopharmaceutical manufacturers offer versatile and robust solutions to enhance productivity and maintain high standards of quality and compliance. For instance, in September 2023, Automated Control Concepts (ACC), one of the leading innovators in biotechnology solutions, announced the development of its cutting-edge bioreactor control and data platform, Lab Owl, to redefine the landscape of bioprocessing.

Regional Analysis:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

In 2024, North America accounted for the largest market share of over 39.1%. The North America bioreactors market is witnessing robust growth, fueled by the region's strong emphasis on biopharmaceutical research, development, and manufacturing. Additionally, advancements in bioprocessing technologies, such as single-use bioreactors and automation, are enhancing the efficiency and scalability of biomanufacturing processes. The presence of major pharmaceutical and biotechnology companies, coupled with supportive government initiatives and funding, is further propelling the bioreactors market demand. In February 2024, Thermo Fisher Scientific expanded its manufacturing capacity at its Missouri, U.S. site to produce complex biologic treatments for a range of diseases, including cancer, autoimmune conditions, and rare disorders. Furthermore, the North America bioreactors market is poised for continued growth, driven by technological advancements and increasing biopharmaceutical production demands. For instance, in March 2023, Micro Digital Co. signed a formal contract to supply bioreactors to expand its presence in North America.

Key Regional Takeaways:

United States Bioreactors Market Analysis

In 2024, US accounted for around 87.6% of the total North America bioreactors market. The United States is at the forefront of adopting bioreactor technology, significantly advancing its position in biotechnology and pharmaceutical manufacturing. Bioreactors are streamlining the production of biologics, including vaccines, monoclonal antibodies, and regenerative medicine solutions, addressing both domestic and global healthcare needs. Key advantages include higher production efficiency, scalability, and enhanced process control, enabling faster responses to medical demands. Innovations such as single-use bioreactors are reducing costs and contamination risks while supporting sustainability goals. For instance, The United States, as the world's third-largest importer of bioreactors with 191 shipments, primarily sources from Mexico, India, and Canada. This strategic importation supports advancements in biotechnology and pharmaceuticals, bolstering the nation's innovation and economic growth. Major states like California, Massachusetts, and North Carolina, with robust biotechnology clusters, are hubs for bioreactor deployment, fostering collaborations and driving R&D. These advancements are further strengthening the U.S. position as a leader in life sciences, with companies and research centers contributing to breakthroughs in personalized medicine and cell-based therapies. Bioreactors are transforming industries beyond healthcare, including biofuels and agriculture, enhancing resource management and sustainability efforts across diverse sectors.

Asia Pacific Bioreactors Market Analysis

The Asia-Pacific region is emerging as a significant hub for bioreactor adoption, driven by advancements in biotechnology and the region's focus on pharmaceutical and biopharmaceutical development. Countries such as China, India, Japan, and South Korea are leveraging bioreactor technologies to enhance vaccine production, biologics manufacturing, and regenerative medicine. These innovations are enabling cost-effective and scalable production processes, crucial for meeting the demands of growing healthcare markets. For instance, India imported 2,480 bioreactor shipments from March 2023 to February 2024, primarily from the United States, Switzerland, and Germany. This significant import activity underscores India's commitment to advancing its biotechnology sector, enhancing research capabilities, and fostering economic growth. The region's favorable regulatory frameworks and substantial investments in research hubs, particularly in cities like Shanghai, Hyderabad, and Tokyo, are positioning Asia-Pacific as a leader in bioprocessing. The adoption of single-use bioreactors in South Korea's biopharmaceutical industry and China's focus on monoclonal antibody production exemplify the region's dynamic advancements. With strategic location advantages, including proximity to raw materials and skilled labor, Asia-Pacific is fostering sustainable biotechnology growth, meeting global supply demands, and addressing critical healthcare challenges.

Europe Bioreactors Market Analysis

The adoption of bioreactors in Europe is significantly transforming industries like pharmaceuticals and biotechnology by advancing production efficiency and sustainability. Bioreactors enable precise environmental control, enhancing the yield of biologics and biofuels while reducing waste and resource consumption. Europe, particularly Germany and Switzerland, leads in bioreactor innovation, leveraging advancements in automation and sensor technologies to optimize processes. Germany's pharmaceutical hubs utilize bioreactors to streamline vaccine production, meeting global health demands rapidly. Similarly, Switzerland's biotechnology sector has integrated bioreactors to enhance monoclonal antibody manufacturing, positioning the country as a leader in therapeutic advancements. Switzerland's export of bioreactors and effluent treatment equipment significantly benefits Europe by enhancing wastewater management and environmental sustainability. In 2024, Switzerland exported 2,474 shipments of MBR bioreactor treatment plant sections and related equipment, indicating robust trade activity in this sector. The widespread adoption across European countries, including the Netherlands and France, emphasizes the region's commitment to green technology and reduced carbon footprints. By fostering innovation hubs and research centers, Europe strengthens its position in global biotechnology, offering scalable solutions that address industrial and environmental challenges while maintaining a competitive edge in life sciences.

Latin America Bioreactors Market Analysis

The adoption of bioreactors in Latin America is revolutionizing biotechnology and sustainable production. Advancements in scalable cell culture and fermentation technologies enable efficient vaccine development and bio-based manufacturing. Countries like Brazil are leveraging bioreactors for ethanol production from sugarcane, enhancing renewable energy output. Similarly, Mexico utilizes bioreactors in pharmaceutical innovation, improving drug manufacturing. According to reports, The Mexico small-scale bioreactors market is projected to grow from USD 36.9 Million in 2018 to USD 154.1 Million by 2032, driven by increasing adoption in medical, food, agriculture, and energy sectors. These innovations position Latin America as a global hub for biotechnological progress. Strategically located near global trade routes, the region fosters economic growth through exports. States such as Sao Paulo and Jalisco exemplify leadership, driving technological adoption to support environmental sustainability and economic development.

Middle East and Africa Bioreactors Market Analysis

The Middle East and Africa are rapidly embracing bioreactors, revolutionizing biotechnology, and healthcare sectors. Bioreactors offer advantages such as enhanced cell growth, scalability, and precise environmental control, fostering innovation in pharmaceutical production and wastewater treatment. According to reports, the United Arab Emirates imported 12 bioreactor shipments, ranking 22nd globally. India led with 2,480 shipments, followed by Vietnam with 225, and the United States with 209. Advancements in single-use bioreactors and automation have streamlined operations, making them accessible to emerging markets. For instance, Saudi Arabia is utilizing bioreactors for vaccine manufacturing, ensuring local supply chains, while South Africa is employing them in biofuel production to address energy sustainability. Strategic positioning in these regions promotes economic diversification and self-reliance, making bioreactors a pivotal tool for regional growth.

Competitive Landscape:

The bioreactors market forecast indicates strong competition in the market, as key players iare focusing on innovation to enhance efficiency and scalability in bioprocessing. They are investing in advanced technologies such as single-use systems to meet the growing demand for flexible and cost-effective solutions. Companies are also expanding their portfolios to include modular and custom bioreactors tailored to specific applications such as cell and gene therapy. Along with this, partnerships with biotech firms and research institutions are strengthening R&D efforts, fostering the development of next-generation bioreactors. Additionally, manufacturers are leveraging automation and digital monitoring tools to improve process control and product quality.

The report provides a comprehensive analysis of the competitive landscape in the bioreactors market with detailed profiles of all major companies, including:

2mag AG
bbi-biotech GmbH
Bioengineering AG
Eppendorf SE
Getinge AB
Infors AG
Merck KGaA
Pall Corporation (Danaher Corporation)
Sartorius AG
Solaris Biotechnology Srl
Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1.How big is the bioreactors market?
2.What is the future outlook of the bioreactors market?
3.What are the key factors driving the bioreactors market?
4.Which region accounts for the largest bioreactors market share?
5.Which are the leading companies in the global bioreactors market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Bioreactors Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Single-Use
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Multi-Use
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Usage

7.1 Lab-Scale Production
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Pilot-Scale Production
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Full-Scale Production
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Scale

8.1 5L-20L
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 20L-200L
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 200L-1500L
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Above 1500L
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Control Type

9.1 Manual
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Automated
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 2mag AG
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 bbi-biotech GmbH
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Bioengineering AG
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Eppendorf SE
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Getinge AB
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Infors AG
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Merck KGaA
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Pall Corporation (Danaher Corporation)
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
- 15.3.9 Sartorius AG
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Solaris Biotechnology Srl
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 Thermo Fisher Scientific Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Bioreactors Market: Major Drivers and Challenges
Figure 2: Global: Bioreactors Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Bioreactors Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Bioreactors Market: Breakup by Type (in %), 2024
Figure 5: Global: Bioreactors Market: Breakup by Usage (in %), 2024
Figure 6: Global: Bioreactors Market: Breakup by Scale (in %), 2024
Figure 7: Global: Bioreactors Market: Breakup by Control Type (in %), 2024
Figure 8: Global: Bioreactors Market: Breakup by Region (in %), 2024
Figure 9: Global: Bioreactors (Single-Use) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Bioreactors (Single-Use) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Bioreactors (Multi-Use) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Bioreactors (Multi-Use) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Bioreactors (Lab-Scale Production) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Bioreactors (Lab-Scale Production) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Bioreactors (Pilot-Scale Production) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Bioreactors (Pilot-Scale Production) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Bioreactors (Full-Scale Production) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Bioreactors (Full-Scale Production) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Bioreactors (5L-20L) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Bioreactors (5L-20L) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Bioreactors (20L-200L) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Bioreactors (20L-200L) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Bioreactors (200L-1500L) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Bioreactors (200L-1500L) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Bioreactors (Above 1500L) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Bioreactors (Above 1500L) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Bioreactors (Manual) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Bioreactors (Manual) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Bioreactors (Automated) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Bioreactors (Automated) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: North America: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: North America: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: United States: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: United States: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Canada: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Canada: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Asia-Pacific: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Asia-Pacific: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: China: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: China: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Japan: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Japan: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: India: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: India: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: South Korea: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: South Korea: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Australia: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Australia: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Indonesia: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Indonesia: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Others: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Others: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Europe: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Europe: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Germany: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Germany: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: France: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: France: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: United Kingdom: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: United Kingdom: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Italy: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Italy: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Spain: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Spain: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Russia: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Russia: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Others: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Others: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Latin America: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Latin America: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Brazil: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Brazil: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Mexico: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Mexico: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Others: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Others: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Middle East and Africa: Bioreactors Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Middle East and Africa: Bioreactors Market: Breakup by Country (in %), 2024
Figure 79: Middle East and Africa: Bioreactors Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Global: Bioreactors Industry: SWOT Analysis
Figure 81: Global: Bioreactors Industry: Value Chain Analysis
Figure 82: Global: Bioreactors Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Bioreactors Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Bioreactors Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Bioreactors Market Forecast: Breakup by Usage (in Million USD), 2025-2033
Table 4: Global: Bioreactors Market Forecast: Breakup by Scale (in Million USD), 2025-2033
Table 5: Global: Bioreactors Market Forecast: Breakup by Control Type (in Million USD), 2025-2033
Table 6: Global: Bioreactors Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Bioreactors Market: Competitive Structure
Table 8: Global: Bioreactors Market: Key Players

02-2729-4219

+886-2-2729-4219